🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Eligible participants with newly diagnosed myeloma who are not considered e...
Status
Recruiting
Location
Gundersen Lutheran
Start Date
2026-09
Trial ID
NCT07285239
Multiple myeloma (MM) is an incurable malignancy and accounts for 1 percent...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-06-18
Trial ID
NCT03525678
Treatments Being Tested
This is a phase 1/2, open label, single-center study designed to assess the...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2022-10-20
Trial ID
NCT05581875
Treatments Being Tested
This study aims to evaluate alternative dosing regimens of single-agent bel...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-03-03
Trial ID
NCT05064358
Treatments Being Tested
Multiple myeloma (MM) is a neoplastic plasma cell disorder that is characte...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-12-09
Trial ID
NCT04177823
Treatments Being Tested
This is a phase 1/2, open label, study designed to assess the safety and cl...
Status
Unknown
Location
Department of Clinical Therapeutics, School of Medicine, National Kapodistrian University of Athens (NKUA)
Start Date
2022-04-13
Trial ID
NCT05280275
Treatments Being Tested
To increase the conversion rate from MRD-positive to MRD-negative CR in pat...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2022-12-01
Trial ID
NCT05091372
Treatments Being Tested
This is a phase I/II, single arm, open label, two-part study that will asse...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-03-14
Trial ID
NCT03848845
Treatments Being Tested
This phase I/II trial tests the safety, side effects, best dose, and effect...
Status
Recruiting
Location
Mary Greeley Medical Center
Start Date
2025-04-23
Trial ID
NCT06232044
This is a research study to find out if a drug called belantamab mafodotin ...
Status
Not Yet Recruiting
Location
Johnston Hematology and Oncology of Clayton
Start Date
2026-05
Trial ID
NCT05874193
Treatments Being Tested